30588

30588
Fedgchin M, Trivedi M, Daly EJ, et al. Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1). The international journal of neuropsychopharmacology 2019; 22(10):616–30. DOI: 10.1093/ijnp/pyz039. http://www.ncbi.nlm.nih.gov/pubmed/31290965.
Einstellungen
30588
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 07.09.2022 | 12:24 Uhr